BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  RadioMedix Selected for National Cancer Institute’s Investor Initiatives and Presentation at BIO Investor Forum

  t is a unique opportunity to present pipeline of RadioMedix products and offer clinical and R&D services to biopharma experts and investors.

  October 17, 2017

   · 

  2 min read
• Genetown

  WuXi NextCODE At ASHG: Population Genomics, Unleashing Cancer Data, Diagnosing Rare Disease, The Internet Of DNA

  WuXi NextCODE, the global standard platform for genomic data, invites attendees at the American Society of Human Genetics annual meeting being held this week in Orlando to visit booth #1031.

  October 17, 2017

   · 

  2 min read
• Business

  Bovie Medical Corporation to Release Third Quarter 2017 Financial Results on November 2, 2017

  Bovie Medical announced that financial results for the third quarter of 2017 will be released after the market closes on Thursday, November 2.

  October 17, 2017

   · 

  2 min read
• Biotech Bay

  Biotime, Inc. Announces Closing Of Public Offering And Underwriters’ Full Exercise Of Over-Allotment Option

  BioTime, Inc. announced the closing of its previously announced public offering of 9,615,385 shares of common stock, including 1,442,308 shares sold pursuant to the underwriters’ exercise in full of their option to purchase additional shares.

  October 17, 2017

   · 

  3 min read
• Business

  Catapult Ventures Appoints Kevin D’Silva As Venture Partner

  Catapult Ventures has announced that Kevin D’Silva has been appointed as a Venture Partner with its GM&C Life Sciences Fund.

  October 17, 2017

   · 

  3 min read
• Drug Development

  iSTAR Medical Completes Enrollment Of First-In-Human Migs Trial

  iSTAR Medical announced today the completion of enrollment in their first-in-human (FIH) micro-invasive glaucoma surgery (MIGS) trial for the MINIjectTM device.

  October 17, 2017

   · 

  2 min read
• Pharm Country

  RenovaCare Closes Registered Direct Offering And Concurrent Private Placement

  Renovacare announced that it has entered into definitive agreements with investors to purchase an aggregate of approximately 915,000 shares of common stock in a registered direct offering and common stock purchase warrants in a concurrent private placement.

  October 17, 2017

   · 

  7 min read
• Job Trends

  Anpac Bio Surpasses 50,000 Case Study Milestone ‘Liquid Biopsy Pioneer’ Serving Individual, Medical, Insurance & Corporate Customers

  Dr. Chris Yu, CEO of international life sciences corporation Anpac Bio-Medical Science Company, announced this week the company set a new, international record, processing and reporting over 50,000 cases worldwide of the company’s proprietary, “Cancer Differentiation Analysis” (CDA) liquid biopsy tests.

  October 17, 2017

   · 

  2 min read
• Policy

  Teva Announces Submission Of Biologics License Application For Fremanezumab To The U.S. FDA

  Teva Pharmaceutical Industries Ltd., today announced the submission of a Biologics License Application (BLA) to FDA for fremanezumab, an anti-calcitonin gene-related peptide (anti-CGRP) monoclonal antibody for the preventive treatment of migraine.

  October 17, 2017

   · 

  8 min read
• Genetown

  Myomo Launches Awareness Program for Veterans of the U.S. Armed Forces

  Myomo, Inc. today announced the launch of MyoPro For Veterans, a strategic awareness program that broadens accessibility of MyoPro powered upper limb orthotics (arm brace).

  October 17, 2017

   · 

  5 min read